Hormone replacement therapy and endothelial function: Results of a randomized controlled trial in healthy postmenopausal women

Atherosclerosis

Volumn 159, Issue 2, 2001, Pages 357-365

  De Kleijn, Miriam J J ^a   Wilmink, Hanneke W ^a   Bots, Michiel L ^a   Bak, Annette A A ^a   Van der Schouw, Yvonne T ^a   Planellas, Juan ^b   Engelen, Sylvia ^b   Banga, Jan Dirk ^a   Grobbee, Diederick E ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b NV ORGANON   (Netherlands)

Author keywords

Cardiovascular disease; Estrogen; Prevention; Therapy

Indexed keywords

CONJUGATED ESTROGEN; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; GLYCERYL TRINITRATE; MEDROXYPROGESTERONE ACETATE; PLACEBO; TIBOLONE;

ADULT; ARTERY DILATATION; ARTERY ENDOTHELIUM; ARTICLE; BRACHIAL ARTERY; CARDIOVASCULAR RISK; CELL FUNCTION; CLINICAL TRIAL; CONCENTRATION RESPONSE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HORMONE SUBSTITUTION; HUMAN; HYPEREMIA; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICS; TREATMENT OUTCOME;

AGED; CARDIOVASCULAR DISEASES; CONFIDENCE INTERVALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; ENDOTHELIUM, VASCULAR; ESTROGENS, CONJUGATED (USP); FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MEDROXYPROGESTERONE; MIDDLE AGED; NORPREGNENES; POSTMENOPAUSE; REFERENCE VALUES;

EID: 0035199203     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(01)00507-X     Document Type: Article

References (40)

1. Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence
2. Effects of hormone replacement therapy on reactivity of atherosclerotic coronary arteries in cynomolgus monkeys
3. Short-term administration of estrogen and vascular responses of atherosclerotic coronary arteries
4. Effects of oestrogen and progesterone on age-related changes in arteries of postmenopausal women
5. Blood flow variations in internal carotid and middle cerebral arteries induced by postmenopausal hormone replacement therapy
6. A double-blind, placebo controlled study of postmenopausal oestrogen replacement therapy and carotid artery pulsatility index
7. The effect of progestagens on the carotid artery pulsatility index in postmenopausal women on oestrogen replacement therapy
8. Effect of hormone replacement therapy on non-invasive cardiovascular haemodynamics
9. Hormonal therapy increases arterial compliance in postmenopausal women
10. Coronary risk factors, endothelial function, and atherosclerosis: A review
11. Estrogen modulates responses of atherosclerotic coronary arteries
12. Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women
13. Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women
14. Hormone replacement therapy is associated with improved arterial physiology in healthy post-menopausal women
15. Arterial reactivity is enhanced in genetic males taking high dose estrogens
16. Long-term estrogen therapy improves vascular function in male to female transsexuals
17. Estradiol therapy combined with progesterone and endothelium-dependent vasodilation in postmenopausal women
18. Individual and combined effects of estrogen/progestin therapy and lovastatin on lipids and flow-mediated vasodilation in postmenopausal women with coronary artery disease
19. Differential effects of oral and transdermal estrogen replacement therapy on endothelial function in postmenopausal women
20. Combined hormone replacement therapy does not protect women against the age-related decline in endothelium-dependent vasomotor function
21. Long-term effects of combined hormone replacement therapy on markers of endothelial function and inflammatory activity in healthy postmenopausal women
22. Hormones and metabolism, estrogen/progestagen, other combined therapies
23. A 2-year study of lipid and lipoprotein changes in postmenopausal women with tibolone and estrogen-progestin
24. The effects of tibolone
25. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults
26. Differences in the effect of cigarette smoking on endothelial function in Chinese and white adults
27. Lipoprotein (a) impairs endothelial function in healthy postmenopausal women
28. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis
29. Estrogens, progestins, and heart disease: Can endothelial function divine the benefit?
30. Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women
31. Effect of 17 beta-estradiol on endothelium-dependent responses in the rabbit
32. The protective effects of estrogen on the cardiovascular system
33. Acute vascular effects of estrogen in postmenopausal women
34. Vascular effects of estrogen and cholesterol-lowering therapies in hypercholesterolemic postmenopausal women
35. Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women
36. Progesterone and modulation of endothelium-dependent responses in canine coronary arteries
37. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women
38. Androgen deprivation is associated with enhanced endothelium-dependent dilatation in adult men
39. Vascular reactivity is impaired in genetic females taking high-dose androgens
40. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women